Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine
Authors
Keywords
-
Journal
HEADACHE
Volume 55, Issue 9, Pages 1218-1224
Publisher
Wiley
Online
2015-09-18
DOI
10.1111/head.12657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine
- (2014) Regina Rendas-Baum et al. Health and Quality of Life Outcomes
- Treatment of Major Depressive Disorder Using Botulinum Toxin A
- (2014) Michelle Magid et al. JOURNAL OF CLINICAL PSYCHIATRY
- What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients
- (2013) Antonia FH Smelt et al. CEPHALALGIA
- Evaluation of Self-Esteem and Depression Symptoms in Depressed and Nondepressed Subjects Treated with OnabotulinumtoxinA for Glabellar Lines
- (2013) Doris Hexsel et al. DERMATOLOGIC SURGERY
- Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial
- (2013) Eric Finzi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
- (2013) Stephen D. Silberstein et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
- (2012) Dawn C. Buse et al. HEADACHE
- Psychiatric comorbidities of episodic and chronic migraine
- (2012) Dawn C. Buse et al. JOURNAL OF NEUROLOGY
- Facing depression with botulinum toxin: A randomized controlled trial
- (2012) M. Axel Wollmer et al. JOURNAL OF PSYCHIATRIC RESEARCH
- OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
- (2011) R. B. Lipton et al. NEUROLOGY
- Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionna
- (2011) Karen L. Smarr et al. ARTHRITIS CARE & RESEARCH
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
- (2010) Min Yang et al. CEPHALALGIA
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- Tracing transformation: Chronic migraine classification, progression, and epidemiology
- (2009) R. B. Lipton NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now